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The outcome of Leishmania infection depends on parasite abilities to evade host immune
response and its survival in hostile environment of host macrophages. Despite a wealth
of gained crucial information, parasite strategies by which it dampens host macrophage
functions remain poorly understood. Micro RNAs (miRNAs) are evolutionarily conserved
class of endogenous 22-nucleotide small non-coding RNA gene products, described
to participate in the regulation of almost every cellular process investigated so far. In
this study, we identified 940 miRNAs in Leishmania donovani infected macrophages by
de novo sequencing out of which levels of 85 miRNAs were found to be consistently
modified by parasite infection. Herein, we report the functional characteristics of 10
miRNAs i.e., mir-3620, mir-6385, mir-6973a, mir-6996, mir-328, mir-8113, mir-3473f,
mir-763, mir-6540, and mir-1264 that were differentially but constantly regulated in
infected macrophages for their role in regulation of macrophage effector functions. The
target gene prediction and biological interaction analysis revealed involvement of these
miRNAs in various biological processes such as apoptosis inhibition, phagocytosis,
drug response, and T cell phenotypic transitions. These findings could contribute for
the better understanding of macrophages dysfunction and leishmanial pathogenesis.
Further, the identified miRNAs could also be used as biomarker/s in diagnosis, prognosis,
and therapeutics of Leishmania infection.
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INTRODUCTION
Leishmaniasis is considered as neglected tropical disease however, at present it is prevalent in
more than 98 countries and associated with significant mortality and morbidity (Alvar et al.,
2012). Out of 53 described species of Leishmania parasites, 20 are known to cause human
pathogenesis (Akhoundi et al., 2016). All Leishmania species exhibit digenetic life cycle; first, the
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flagellated extracellular infective promastigote form that resides
in the gut of sand fly; and second, a non-flagellated amastigote
form, which resides within phagolysosomal compartment of
host macrophages (Kamhawi, 2006). Based on its clinical
manifestations, the disease is classified into three types:
cutaneous (CL), mucocutaneous (MCL), and visceral (VL)
leishmaniasis, which differ in their immunopathologies, degree
of morbidity and mortality.
Approximately 350 million people are at risk worldwide by
all three forms with 12 million cases of infection (Akhoundi
et al., 2016). In disease endemic countries, the estimated annual
incidence of CL is ∼0.7–1.3 million cases and 0.2–0.4 million
cases of VL (WHO, 2016). More than 90% of VL cases come
from six countries i.e., Brazil, Ethiopia, India, Somalia, South
Sudan, and Sudan (WHO, 2016). VL is caused by Leishmania
donovani in Indian subcontinent, by Leishmania infantum in
North Africa and Southern Europe and by Leishmania chagasi
in Latin American countries. Out of three pathogenic states, VL
infections are fatal, if left untreated and responsible for ∼40,000
deaths per year, worldwide (Ready, 2014).
The chemotherapeutics measures to control leishmanial
infections are very limited and lack of a vaccine, either
prophylactic or preventive, further complicates this issue.
The pentavalent antimonial compounds, considered only true
antileishmanial, have been the mainstay to treat VL soon after
identification of Leishmania parasites. Although, antimonials are
in use till date but parasites resistance to these compounds
are being reported at an alarming rate especially in Indian
subcontinent (Chakravarty and Sundar, 2010). In lieu of an
alternative antileishmanial drug, leishmanial infections are being
treated by either antimicrobial such as pentamidine (originally
developed in search of a hypoglycemic agent and were used in
treatment of African trypanosomiasis in late 1930s), anti-fungal
(amphotericin B, used in early 1960s to treat leishmaniasis), or
antitumor (miltefosine; 1998) drugs, which are also associated
with serious side effects (Jha, 1983; Croft et al., 1987; Mishra et al.,
1992; Fouce et al., 1998; Sundar et al., 1998). Later, in the year
1999 a liposomal formulation of amphotericin B (ambisome) was
approved by Food and Drug Administration (Meyerhoff, 1999).
Out of these three drugs, only ambisome and miltefosine are
currently being used in disease endemic regions. These drugs
never produce sterile cure and as a consequence few individuals
develop post kala-azar dermal leishmaniasis (PKDL) even after
successful cure, which again results in serious morbidity and
mortality (Mukhopadhyay et al., 2014). In addition, resistance
has also been observed against these two drugs in clinical isolates
(Purkait et al., 2012; Mishra and Singh, 2013). Therefore, in lieu
of unavailability of a vaccine and a serious threat for development
of drug resistant parasites against current drug regimen, the
search for alternate control strategies are highly needed to
counter leishmanial infections.
Leishmania, a protozoan intracellular parasite, resides and
proliferate in hostile environment of host macrophages, by
smartly silencing their effector properties, which is characterized
by decreased production of reactive oxygen species (ROS),
nitric oxide (NOx), and pro-inflammatory cytokines such as
TNF-α and IL-12 (Kima, 2007). In addition, the parasite also
alters adaptive immune response and activates anti-inflammatory
Th2 type T cells that suppress proliferation and functions
of Th1 type T cells (Gannavaram et al., 2016). Indeed, all
these events favor Leishmania persistence through inhibition of
inflammatory cytokines production, poor antigen presentation
and altered cellular signaling pathways in the favor of parasite
survival (Chakraborty et al., 2005). The host resistance in
leishmaniasis is related to effective clearance of parasites
by macrophages and establishment of Th1 type immunity
whereas an active IL-10 producing Th2 response is linked
to disease susceptibility (Gupta et al., 2013; Ganguli et al.,
2015).
Notwithstanding few host and parasitic factors responsible
in suppression of macrophage effector properties are known
but the exact mechanisms of macrophage dysfunction are
largely unknown. MicroRNAs (miRNAs) are a subset of short
non-coding RNAs, ∼22 nucleotide (nt) long sequences that
constitute an evolutionarily conserved system, associated with
the regulation of biological and molecular functions at the post-
transcriptional level by base pairing with target mRNAs (Bartel,
2004). They regulate the expression of target genes at the levels of
mRNA stability and translation and help in survival of both, intra
and extra cellular parasites (Bartel, 2009; Lu and Rothenberg,
2013; Baroni and Arrigo, 2014).
The role of various miRNAs such as miRNA-210 in
Leishmania major, miRNA-29c in tuberculosis, miRNA-16 in
malaria, miRNA-181 in Helicobacter pylori infection, miRNA-
150 and miRNA-146b-5p in human immunodeficiency virus
(HIV) have been found to be associated with either resistance
or susceptibility (Wang et al., 2008; Lemaire et al., 2013;
Verma et al., 2016). However, the way miRNAs regulate host
macrophage effector functions in L. donovani infection remains
to be elucidated. In this study, we identified 940 miRNAs of
host macrophages by de novo sequencing and analyzed the
functions of 10 miRNAs, which were differentially regulated for
their regulatory roles in macrophage functions. Using defined
experimental approaches i.e., expression profiling, gene ontology,
and sequencing, this study provides evidence that the L. donovani
strongly induces macrophage miRNAs that eventually down
regulate its effector properties.
MATERIALS AND METHODS:
L. donovani Promastigotes and
Macrophage Culture
L. donovani (AG83) parasites were used in this study. The
parasites virulence was maintained in BALB/c mice through
serial passage. The motile promastigote forms of parasite were
cultured in complete Dulbecco’s Modified Eagle Medium (pH
7.2) (DMEM, Gibco, USA) containing 10% heat-inactivated fetal
bovine serum (FBS, Gibco, USA), 2 mM L-glutamine, sodium
bicarbonate, and antibiotics (Sigma Chemicals, USA); penicillin
(100U/ml), streptomycin (100µg/ml), gentamycin (20µg/ml) at
26◦C in a BOD incubator. RAW 264.7 mice macrophage cell line
procured from NCCS Pune, was maintained in DMEM medium
supplemented with 10% FBS at 37◦C in a humidified mixture of
5% CO2 atmosphere for further studies.
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Parasite Infection and RNA Isolation
Macrophages were infected with parasites for 6 h. After
incubation, cells were thoroughly washed to remove non-
internalized parasites and further cultured in fresh DMEM
with 10% FBS and antibiotics in CO2 incubator at 37
◦C
supplemented with 5% CO2. The cells without infection were
used as control. After 24 h incubation post infection, total
RNA was extracted using Tri R© reagent (Sigma Chemicals, USA)
followingmanufacturer’s instructions. Briefly, cells were collected
and pelleted by centrifuged at 500 g at 4◦C for 15 min. The
supernatant was removed and the cells were washed with PBS
to remove complete media. The cells were then lysed in 300 µl
of Tri R© reagent and 120 µl chloroform. The suspension was
centrifuged at 8,000 g at 25◦C for 10 min. The upper aqueous
layer was recovered and twice amount of isopropanol was added.
The mixture was centrifuged again at 8,000 g at 4◦C for 10 min
and RNA pellets were collected. Finally, RNA pellets were washed
three times with 70% DEPC ethanol to remove the impurities.
Total RNAwas first digested with RNAse free DNase (Fermantas,
Germany) to avoid DNA contamination before use. Isolated
RNAs were immediately preserved at−80◦C.
Small RNA Library Validation and
Next-Generation Sequencing
Small RNA Library was prepared using TrueSeq small RNA
library prep kit (Illumina San Diego CA, USA) according to
the manufacturer’s instruction. This whole procedure requires
adapter ligation, reverse transcription, PCR amplification, and
pooled gel purification to generate a library product. For
targeting miRNAs having a 3′ hydroxyl group resulting from
enzymatic cleavage by Dicer or other RNA processing enzymes,
RNA 3′ adapter was specifically modified to target miRNAs.
Further, Adapters were ligated to each end of the RNAs and
subsequently reverse transcribed to create single-stranded cDNA
and sequenced using miRNA sequencing on an IlluminaHiSeq
2000 platform (Illumina, San Diego, CA, USA). By using a DNA
specific chip 1 µl of the resuspended library construct was loaded
on Agilent Technologies 2100 Bioanalyzer chip for small RNA
Library validation. Prior to the sequencing, all the individual
libraries were clustered together using TrueSeq Cluster kit V3-
cBot-HS (HiSeq) in a single lane on an IlluminaHiSeq 2000
platform that generated 0–100 bp paired end reads.
Data Extraction and Analysis; Raw Data
Filtering and miRBase V19 Mapping
The raw data generated earlier in FastQ format was further
filtered for high quality (>Q20 bases) reads of which low
quality reads were removed and low quality bases were trimmed.
Following adaptor sequences trimming, reads <18 bases were
discarded as too short. Further, filtered high quality raw data was
mapped on to miRBase V19. Same-strand matches of sRNAs to
the miRBase databases were reported. The 0–3 mismatches were
allowed for the search against miRBase. During this following
reports were produced; miRNAs hits in an excel sheet along
with matching coordinates in the genome and the precursor
sequence. The miRNAs were matched with different variants of
the miRNAs, such as: different mature sequences that can arise
from the same precursor, annotated in miRBase as −5p, −s, or
−as in the ID of the miRNA. Different precursors producing the
same mature sequence, annotated as−1,−2, etc., in miRBase.
Differential miRNA Expression
The Excel sheet provided contained information about total and
non-redundant (unique) sequence counts for each sample. Data
obtained for each sample after the final filtering step was used for
normalization. The normalized counts were given in “matching
reads per 1 million total reads” to make them comparable
between samples.
Genome Mapping and miRNA Prediction
Criteria
The filtered sequences were further mapped to a genome of
interest using PATMAN software with each mapping locus
sequences with abundance of 5 or more being tested as miRNAs.
Small RNAs read between 18 and 25 nt were considered as
potential miRNA candidates and were tested as miRNAs. Along
with this the length of sequences with 16 or fewer genomic
matches were also tested as miRNAs. After the sequences mapped
to the input genome, the clusters of sequences matching certain
criteria were looked up by the software. Once a list of clusters
was produced they were further analyzed in order to find likely
miRNA candidates. The most abundant small RNA read within
a cluster was chosen as the likely miRNA. Flanking sequences
surrounding small RNA was extracted from the genome using
a variety of window lengths. Each sequence window was then
folded using RNA fold. After trimming, the resulting secondary
structures were analyzed to see whether they look like a miRNA
hairpin. Further, additional checks were performed so that there
were no more than three consecutive mismatches, at least 18–25
nucleotide centered around the miRNA are involved in base-
pairing and the hairpin is at least 75 nucleotide in length.
Depending on the values set at submission at least 50% of bases in
the hairpin should be paired. The most stable valid hairpin from
each of the sequence windows was then chosen as the precursor
miRNA candidate. After that the precursor miRNA candidate
was tested using Randfold (using a cutoff of 0.1).
Quantitative Real Time Validation of
Identified miRNAs
For cDNA preparation, 1 µg total RNA (kept equal for each
amplification) was subjected to reverse transcription using 20U
M-MLV reverse transcriptase (Fermantas, Germany), 1X RT
buffer, 20 mM dNTPs (New England Biolabs, USA), 20U RNasin
(Fermentas, Germany), 0.1 M DTT with DEPC treated water,
and 100 ng of random hexamers (Fermentas, Germany). The
expression levels were quantified on ABI7500 Fast system as per
manufacturer instructions (Applied Biosystem) using 5 pmol/µl
of specific primers with snoRNA142 being taken as endogenous
control. Briefly, 20 µl of real time mix contained 10 µl of Power
SYBER green master mix (Applied Biosystem), 1 µl cDNA, 6
µl MilliQ water and 1.5 µl of forward, and reverse primers.
PCR conditions were set with an initial incubation of 50◦C for
2 min, followed by denaturation at 95◦C for 10 min, and 40
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cycles at 95◦C for 15 s, 60◦C for 1 min, and 72◦C for 40 s. The
abundance/ decline of miRNA were normalized to geometric
average of endogenous control snoRNA142 for 1Ct. The fold
change (1Ct) was calculated as the difference between infected
groups vs. non-infected RAW 264.7 macrophages. The mRNA
expression levels were quantified at 24 h post infection.
Statistical Analysis
Statistical analysis of differences between means of groups
was determined by two-tailed Student t-test and ANOVA on
GraphPad Prism 5.0 software. A p < 0.05 was considered
significant, and a p< 0.01 was considered highly significant.
RESULTS
L. donovani Infection in Macrophages
To identify altered miRNAs after L. donovani infection, we
infected macrophages with L. donovani (AG83) parasites for
6 h. The intracellular amastigotes in infected macrophages
were stained with Diff-Quick (Baxter Healthcare, USA).
Approximately 70% macrophages were infected by parasites
with a count of 400 ± 250 (mean ± SD) parasites per 100
macrophages that were assessed microscopically after 24 h post
infection. After 24 h (total 30 h), total RNA was extracted using
Tri reagent (Sigma) for further total transcriptome sequencing
to identify miRNAs.
Clustering of Differentially Regulated
miRNAs Led Us to Identify 10 Differentially
Regulated miRNAs in Infected
Macrophages
We describe here a full-scale complete analysis of the
miRNA profiles in infected macrophages. A total of
940 miRNAs were identified in parasites infected cells
(Supplementary Table 1), out of which 150 miRNAs, shown
in heat map (Supplementary Figure 1), were analyzed further.
Further, expecting an outsized inter individual unevenness
in miRNA expression, we only selected miRNAs that showed
consistent tendency of deregulation (either up or down
regulated) in the L. donovani infection. According to this
criterion, only 85 miRNAs (out of 150 miRNAs) had levels
consistently modified by L. donovani (Supplementary Table 2).
On the basis of constant differential expression in parasites
infected macrophages, we chose 10 miRNAs (mir-3620, mir-
6385, mir-6973a, mir-6996, mir-328, mir-8113, mir-3473f,
mir-763, mir-6540, and mir-1264) for their further role in the
regulation of macrophage effector functions such as oxidative
stress response, phagocytosis, apoptosis, drug response and role
in B/T cells lineage commitment, etc.
The Quantitative PCR Further Confirmed
the Up and Down Regulation of Identified
miRNAs
In order to validate the miRNA differential expression data, the
quantitative real time PCR (qRT PCR) was done on identified
10 miRNAs. The relative differential expression miRNA was
quantified with snoRNA142 that was taken as endogenous
miRNA control. Both, the data generated by PCR-array and
qRT-PCR confirmed up regulation of mir-6996, mir-3620, mir-
6973a, and mir-6385 with fold change 14.56 ± 0.9895 (p =
0.0053), 7.823 ± 1.201 (p = 0.0296), 4.595 ± 0.8213 (p =
0.0484), and 8.831 ± 1.158 (p = 0.0212) and down regulation
of mir-6540, mir-1264, mir-328, mir-763, mir-3473f, and mir-
8113 with fold change −1.505 ± 0.4726 (p = 0.0338), −2.318
± 0.7683 (p = 0.0497), −9.688 ± 2.339 (p = 0.0447), −8.109
± 2.047 (p = 0.0470), −19.1 ± 1.622 (p = 0.0065), and
−17.58 ± 2.937 (p = 0.0241), respectively as shown in the
Figure 1.
The de novo Sequencing Led Us to Identify
52 Novel miRNAs
The sequencing data after the removal of ligation adapters were
analyzed using miRDeep2 tool for the identification of novel
miRNAs. A total of 52 novel miRNAs were identified as potential
miRNA candidate gene. For each of the novel miRNAs, the
corresponding miRNAs precursor and mature sequence were
also identified, which confirmed their existence as miRNAs.
The chromosome number 10 contains the most number
(eight) of novel miRNAs followed by chromosome one which
contains six novel miRNAs. There were two novel miRNAs
(consensus mature sequence “CUGUACUGUGGAGCCAGC”
and “UGGGCAACAGCAGGUCUG”) that were present in
more than 800 copy numbers (Supplementary Table 3).
These two miRNAs need to be further investigated
for their role in leishmanial pathogenesis and
susceptibility.
FIGURE 1 | Relative expression of miRNAs in infected macrophages.
Macrophages were infected with L. donovani in a ratio of 1:10 (macrophage:
parasite) for 6 h, and then thoroughly washed to remove non-ingested
parasites. Macrophages were further incubated at 37◦C for 24 h and total
RNA was isolated from lysed cells. The miRNAs, mir-6996, mir-3620,
mir-6973a, and mir-6385 were found significantly up regulated whereas
mir-6540, mir-1264, mir-328, mir-763, mir-3473f, and mir-8113 were found
significantly down regulated.
Frontiers in Microbiology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 314
Tiwari et al. Identification of miRNAs Involved in Macrophage Dysfunction
The miRNA Target Network Validation:
Identification of miRNA Targeted Biological
Processes, Molecular Functions and
Cellular Components in Infected
Macrophages
For the identification of the transcripts that might be targeted
by differentially regulated miRNAs in infected macrophages, we
used the validated module of miRBase database to extract miR
interaction information. With this approach, several remarkable
transcripts virtually targeted by deregulated miRNAs over the
infection time course were obtained. The interaction network
between miRNAs and miRNA targeted biological processes,
molecular functions and cellular components were constructed
in Cytoscape 3.2.1 after GO enrichment (Praneenararat et al.,
2012).
The miRNAs Were Found to Regulate
Various Biological Processes Linked to
Macrophage Dysfunction and Survival in
Parasite
Biological processes were inferred from analysis of both,
up and down regulated miRNA targets, which are depicted
in Figures 2A,B, respectively. The list of miRNAs linked
pathways is given in Supplementary Tables 4, 5 for up and
down regulated pathways, respectively. The GO enrichment
identified the involvement of these miRNAs in various biological
processes such as cell cycle (mir-3620), cytokine response
(mir-3473f and mir-6385), cell proliferation (mir-3473f and
mir-8113), response to LPS (mir-6996), Th1/Th2 phenotype
dichotomy (mir-3473f and mir-8113), phagocytosis (mir-328),
protein complex assembly and it’s stabilization (mir-6385), ROS
metabolism (mir-3473f), response toward oxidative stress (mir-
3473f), apoptosis (mir-3473f, mir-8113, and mir-6385), immune
response (mir-6996 and mir-6385), and JAK-STAT signaling
pathway (mir-763 and mir-6996). These all biological processes
are relevant not only for host cells but also to counter attack
intracellular parasites.
The Identified miRNAs Were Found to be
Associated with Important Molecular
Functions That May Result in Dampened
Macrophage Effector Functions
The potential molecular functions linked targets for up and
down regulated miRNAs are represented in network diagram
as depicted in Figures 3A,B, respectively. All supporting and
detailed information are clubbed in Supplementary Tables 6, 7,
respectively. The GO enrichment studies revealed association
with protein dimerization (mir-6385), transcription activator
activity (mir-6996), and regulation of zinc ion binding (mir-
6385 andmir-3620). The down regulated miRNAs, were found to
regulate DNA, core promoter, phosphatidylserine binding (mir-
6540) binding, transcription co-activation, and protein homo-
dimerization activities (mir-3473f, mir-763, and mir-6385), and
drug binding pathways (mir-1264), etc. These all molecular
functions especially phosphatidylserine and drug binding are
vital to restrict intracellular parasites survival. Hence, it is with
great value to decipher how alterations of these miRNAs can
result in macrophage dysfunction in leishmanial infection.
Cytoscape Interaction Analysis Identified
the Involvement of miRNAs in Various
Cellular Components Required for Cellular
Functions and Integrity
The interaction analysis revealed that altered miRNAs are located
in the various components such as nuclear, mitochondrial, and
plasma membranes, cytoplasm, endoplasmic reticulum, golgi
membrane, and cytoskeleton, etc. The interactive networks for up
and down regulated miRNAs are depicted in Figures 4A,B. All
supported information is included in Supplementary Tables 8, 9,
respectively.
DISCUSSION
Notwithstanding, we have made considerable progress in
leishmanial diagnostic and pathology however; the parameters
of diseases susceptibility and protective immunity are not
well identified. How does Leishmania prime host macrophages
in its favor? It is still a matter of investigation. In this
study, we identified 150 miRNAs using de novo sequencing
approach, which expression levels were largely altered in L.
donovani infected macrophages. Further, the in silico analysis
acknowledged the important of role of 10 miRNAs that
possibly facilitate parasite survival through down regulation of
macrophage effector genes. In addition, this approach led us
to identify two novel miRNAs that were present in huge copy
numbers (>800), which suggested that Leishmania significantly
alters host miRNAs machinery in its favor at early stage of
infection.
Leishmania species are digenetic obligatory intracellular
parasitic protozoans that reside inside two hostile environments
i.e., the midgut of the insect vector, and the phagolysosomes
of the mammalian macrophages (Sadlova et al., 2016). The
initial interaction between the host cell and parasite determines
whether parasite will make silent entry in macrophages and
persist or host will eliminate the parasite (Stager et al., 2010).
Since the identified miRNAs were altered soon after infection
i.e., 30 h post infection, it seems that Leishmania significantly
inhibits these biological processes through invention in gene
regulatory mechanisms. During the initial phase, a variety of
host cell receptors (CR1, CR3) and parasite molecules (LPG,
gp63) facilitate entry of parasites in host macrophages albeit
the exact mechanisms are not well understood. It is established
that Leishmania expresses phosphatidylserine (PS) in the outer
leaflet of cytoplasmic membrane, which acts as a signal for the
macrophages and enables silent invasion (Liu and Uzonna, 2012).
It is also believed that the parasite expresses equal proportion
of phosphatidylserine on dead parasites as compared to viable
parasites. The dead parasites are engulfed by the macrophages
silently without activating them as they are supposed to be
harmless. This enables the normal viable parasites to enter
silently within the macrophages either at the same time when
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FIGURE 2 | (A) Predicted biological processes of up regulated miRNAs after GO enrichment. The interlinked miRNAs and important pathways linked to macrophages
effector functions such as phagocytosis, ROS metabolic process, B/T cell differentiation, etc. during pathogenic invasion are highlighted with yellow color. (B) The
interaction of down regulated miRNAs and their targeted biological processes. The highlighted yellow color denotes interlinked miRNAs with key biological processes
relevant to macrophage dysfunction such as cytokine response, immune response, negative regulation of apoptotic process, response to oxidative stress, etc.
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FIGURE 3 | (A) Molecular network of up regulated miRNAs. All interlinked miRNAs and their respective targets have been highlighted with yellow color. The important
molecular functions linked to cellular dysfunction such as DNA, enzyme and actin binding are highlighted with yellow color. (B) Analysis of molecular functions of down
regulated miRNAs in L. donovani infected RAW 264.7 macrophages at 24 h post-infection with highlighted yellow color denoting important molecular functions such
as drug binding, phosphatidylserine binding, protease, and transcription factor binding, etc.
phosphatidylserine expressing dead parasites are phagocytized
or later. We identified a miRNA, mir-6540 that was linked
to phosphatidylserine binding and significantly down regulated
therefore; further studies might be handy to reveal silent entry of
Leishmania in host macrophages.
Leishmania promastigotes are highly susceptible in blood
stream of infected host therefore, they ligate host cell receptors
and trigger phagocytosis for internalization to increase their
chances of survival soon after the infection (Ueno and Wilson,
2012; Gupta et al., 2013). The parasites acquire nutrients
especially cations for its transformation and replication in
the host phagolysosomes. The regulation of phagocytosis and
phagocytic vesicle formation was found associated with the
biological processes affected by mir-328, which was down
regulated in infected cells that further offers a candidate for
investigation. Further, after phagocytosis parasite requires little
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FIGURE 4 | (A) Associated cellular components of up regulated miRNAs with interlinked miRNAs and their respective key cellular compartments highlighted with
yellow color such as nucleoplasm, cytoplasm, and intracellular, etc. (B) Cellular components inferred from analysis of down regulated miRNA-targets. The highlighted
yellow color denotes interlinked miRNAs and their respective key cellular components like cytoplasm, plasma membrane, mitochondrion, and cell junction, etc.
time for its growth and replication; therefore, it is quite likely
that it delays host cell apoptosis along with down regulating
macrophages effector properties (Moore and Matlashewski,
1994). The mir-3473f, mir-763, and mir-8113 were found to be
associated with negative regulation of apoptotic process, which
further suggested the possibility of these miRNAs to obstruct
normal functions of macrophage activation.
Leishmania possess lipophosphoglycan2 (LPG2) and
leishmanolysin (gp63), which are well known modulators of
host immune response via regulation of its complement and
phagocytosis process along with nitric oxide-mediated signal
transduction (Olivier et al., 2005). Therefore, their association
with host miRNAs expression may reveal its survival strategies
in host macrophages. We found a strong association of mir-6996
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toward LPS thus it is likely that this miRNA might be involved
in LPG and gp63 related signaling and dominance on host
macrophages as its expression in infected cells was significantly
up regulated.
In visceral Leishmaniasis, the host ability of parasite resistance
is characterized by generation of Th1 response, which produce
pro-inflammatory cytokines such as IL-2, IL-12, etc. whereas
generation of Th2 response, characterized by IL-4 and TGF-
β secretion, favors for survival of the parasite inside the
host (Singh et al., 2012; Rodrigues et al., 2014). So far, the
host and parasitic factors responsive for the Th1 to Th2
paradigm shift are not identified. We found that mir-3473f
and mir-8113 might be the possible candidates to regulate T
cell proliferation, differentiation, and Th1/Th2 dichotomy in
leishmanial pathogenesis as these were found down regulated,
and hence requires further studies. Further, the highly induced
mir-6973a was found to be associated with IL-12 biosynthesis,
a key molecule in regulating cellular immune system and
essential for activating Th1 responses. Therefore, through up-
regulation of this miRNA, parasite might be able to prevent
IL-12 production and shift protective Th2 type response to
Th2 type for its continual survival and proliferation. Therefore,
these miRNAs may be further investigated for their role in
Leishmania induced Th2 type immune response and Th1 to
Th2 phenotype change. The mir-3473f was also found to
be linked with autophagy inhibition, which further suggests
its possible role in leishmanial pathogenesis as autophagy
keeps a check on intracellular pathogens (Frank et al.,
2015).
Leishmania acquires host divalent cations especially iron for
its cellular division and proliferation and also for peroxidases,
the major defense enzymes in host macrophages (Singh et al.,
2013). Iron homeostasis is an important host strategy to
export iron from macrophage cytoplasm to ensure its least
availability for intracellular parasites. The mir-3620 was found
to be linked to cellular iron homeostasis, and since it was
significantly elevated, possibly it down regulates genes of iron
homeostasis to ensure maximum availability of iron in cell
cytoplasm. In addition, along with mir-3620, the mir-6385 was
also found to regulate hypoxia. Hypoxia induces macrophages
to control leishmanial infections (Degrossoli et al., 2011) since
these miRNAs were highly elevated that probably help to
down regulate hyoxia inducing genes and hence require more
studies.
MiRNAs have also shown to play important role in drug
resistance in both, infectious and non-infectious diseases (To,
2013; Ren et al., 2015). Studies also suggest the role of ldmdr1
and ATP binding cassette (ABC) proteins in disease resistance
and susceptibility in leishmanial pathogenesis (Henderson et al.,
1992; Singh et al., 2014). However, the abnornal expression
of these has not been correlated with miRNAs regulation so
far. The GO enrichment revealed that mir-763, mir-1264, and
mir-3473f also regulate drug response mechanisms. Thus it
is possible that Leishmania induces the macrophages to over
express such proteins (for e.g., ABC transporters) by down
regulating these miRNAs, which help to eﬄux out drugs from
the cell.
CONCLUSION
To conclude, we identified a total of 940 miRNAs by de novo
sequencing in L. donovani infected macrophages. A combination
of 150 miRNAs, which were widely altered in infected
macrophages of which 10 miRNAs were found to play significant
role in the regulation of macrophage effector functions. These
findings emphasize the potential of miRNAs in regulation of
macrophage effector functions and highlight their importance
in leishmanial pathogenesis that can be targeted to curb visceral
leishmaniasis. In addition, the identified miRNAs could also be
used as biomarkers to distinguish various pathological states
such as cured, symptomatic and asymptomatic VL infections,
and also can be used to design new drug targets and control
strategies.
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